Home LiteratureArticle Details
PMID: 6234886 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium.

The Biochemical journal ·Vol. 219 ·No. 3 ·1984-05-01 ·Pages 833-42

Pollock WK, Armstrong RA, Brydon LJ, Jones RL, MacIntyre DE

Abstract

The inter-relationships between receptor occupancy, inositol phospholipid metabolism and elevation of cytosolic free Ca2+ in thromboxane A2-induced human platelet activation were investigated by using the stable thromboxane A2 mimetic, 9,11-epoxymethanoprostaglandin H2, and the thromboxane A2 receptor antagonist, EPO45. 9,11-Epoxymethanoprostaglandin H2 stimulated platelet phosphatidylinositol metabolism as indicated by the rapid accumulation of [32P]phosphatidate and later accumulation of [32P]phosphatidylinositol in platelets pre-labelled with [32P]Pi. These effects of 9,11-epoxymethanoprostaglandin H2 were concentration-dependent and half-maximal [32P]phosphatidate formation occurred at an agonist concentration of 54 +/- 8 nM. With platelets labelled with the fluorescent Ca2+ indicator quin 2, resting cytosolic free Ca2+ was 86 +/- 12 nM. 9,11-Epoxymethanoprostaglandin H2 induced a rapid, concentration-dependent elevation of cytosolic free Ca2+ to a maximum of 300-700 nM. Half-maximal stimulation was observed at an agonist concentration of 80 +/- 23 nM. The thromboxane A2 receptor antagonist EPO45 selectively inhibited 9,11-epoxymethanoprostaglandin H2-induced [32P]phosphatidate formation and elevation of cytosolic free Ca2+, indicating that both events are sequelae of receptor occupancy. Human platelets contain a single class of stereospecific, saturable, high affinity (KD = 70 +/- 13 nM) binding sites for 9,11-epoxymethano[3H]prostaglandin H2. The concentration-response curve for receptor occupancy (9,11-epoxymethano-[3H]prostaglandin H2 binding) is similar to that for 9,11-epoxymethanoprostaglandin H2-induced [32P]phosphatidate formation and for elevation of cytosolic free Ca2+. These observations indicate that human platelet thromboxane A2 receptor occupation is closely linked to inositol phospholipid metabolism and to elevation of cytosolic free Ca2+. Both such events may be necessary for thromboxane A2-induced human platelet activation.

MeSH Terms
Blood Platelets/drug effects,metabolism Calcium/blood Cytosol/metabolism Dose-Response Relationship, Drug Humans In Vitro Techniques Phosphatidic Acids/blood Phospholipids/biosynthesis Platelet Aggregation/drug effects Prostaglandin Endoperoxides, Synthetic/pharmacology Prostaglandin H2 Prostaglandins H/pharmacology Prostaglandins, Synthetic/pharmacology Receptors, Prostaglandin/blood Receptors, Thromboxane Thromboxane A2/pharmacology Thromboxanes/pharmacology
Chemicals
Phosphatidic Acids Phospholipids Prostaglandin Endoperoxides, Synthetic Prostaglandins H Prostaglandins, Synthetic Receptors, Prostaglandin Receptors, Thromboxane Thromboxanes Prostaglandin H2 Thromboxane A2 EP 045 Calcium
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Pollock W K
Armstrong R A
Brydon L J
Jones R L
MacIntyre D E
References (50)
50 references, click to expand
  1. Effects of the numbers and sizes of platelet aggregates on the optical density of plasma.
    Nature. 1967 Sep 2;215(5105):1027-9 PMID: 6053424
  2. Cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Nature. 1969 Nov 8;224(5219):609-10 PMID: 4310361
  3. Changes in 32 p-labelling of platelet phospholipids in response to ADP.
    Br J Haematol. 1972 Nov;23(5):571-85 PMID: 4344206
  4. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.
    Proc Natl Acad Sci U S A. 1974 Feb;71(2):345-9 PMID: 4521806
  5. Changes in 32P-content of phosphatidic acid and the phosphoinositides of rabbit platelets during aggregation induced by collagen or thrombin.
    Br J Haematol. 1974 Feb;26(2):243-53 PMID: 4367705
  6. Inositol phospholipids and cell surface receptor function.
    Biochim Biophys Acta. 1975 Mar 25;415(1):81-47 PMID: 164246
  7. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
    Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994-8 PMID: 1059088
  8. Human platelet secretion and aggregation induced by calcium ionophores. Inhibition by PGE1 and dibutyryl cyclic AMP.
    J Gen Physiol. 1975 Nov;66(5):561-81 PMID: 172596
  9. Phospholipids as ionophores.
    J Biol Chem. 1976 Mar 10;251(5):1326-32 PMID: 1254569
  10. Localization of platelet prostaglandin production in the platelet dense tubular system.
    Am J Pathol. 1976 May;83(2):283-98 PMID: 1266944
  11. Conversions of prostaglandin endoperoxides by glutathione-S-transferases and serum albumins.
    Biochim Biophys Acta. 1976 Dec 20;450(3):450-61 PMID: 1009099
  12. Separation and analysis of 32P-labeled phospholipids by a simple and rapid thin-layer chromatographic procedure and its application to cultured neuroblastoma cells.
    Anal Biochem. 1977 Jun;80(2):430-7 PMID: 889083
  13. Prostaglandin endoperoxides promote calcium release from a platelet membrane fraction in vitro.
    Prostaglandins Med. 1978 Nov;1(5):373-85 PMID: 364508
  14. Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.
    Biochem J. 1978 Sep 15;174(3):921-9 PMID: 215124
  15. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Biochem J. 1978 Oct 15;176(1):83-95 PMID: 215136
  16. Production of diglyceride from phosphatidylinositol in activated human platelets.
    J Clin Invest. 1979 Apr;63(4):580-7 PMID: 220279
  17. Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3',5'-cyclic AMP and cyclic GMP in human platelets.
    Biochim Biophys Acta. 1979 Mar 22;583(3):344-51 PMID: 221045
  18. Triglyceride lipase activity and human platelets.
    Thromb Haemost. 1979 Apr 23;41(2):407-15 PMID: 473119
  19. Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux.
    Am J Pathol. 1979 Aug;96(2):423-38 PMID: 112871
  20. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.
    Pharmacol Rev. 1978 Sep;30(3):293-331 PMID: 116251
  21. The prostanoids in hemostasis and thrombosis: a review.
    Am J Pathol. 1980 Jun;99(3):743-804 PMID: 6992594
  22. Phospholipid metabolism in stimulated human platelets. Changes in phosphatidylinositol, phosphatidic acid, and lysophospholipids.
    J Clin Invest. 1980 Aug;66(2):275-83 PMID: 7400315
  23. Phospholipid turnover as a possible transmembrane signal for protein phosphorylation during human platelet activation by thrombin.
    Biochem Biophys Res Commun. 1980 Nov 17;97(1):309-17 PMID: 6450593
  24. Direct evidence for a role for Ca2+ in amine storage granule secretion by human platelets.
    Thromb Res. 1980 Nov 15;20(4):437-46 PMID: 6782702
  25. Phospholipase A2 activity specific for phosphatidic acid. A possible mechanism for the production of arachidonic acid in platelets.
    J Biol Chem. 1981 Jun 10;256(11):5399-403 PMID: 7240145
  26. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
    Br J Pharmacol. 1981 Jul;73(3):773-8 PMID: 7248665
  27. Effects of any epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets.
    Thromb Haemost. 1981 Apr 30;45(2):103-6 PMID: 6266066
  28. Phosphatidylinositol hydrolysis: a multifunctional transducing mechanism.
    Mol Cell Endocrinol. 1981 Nov;24(2):115-40 PMID: 6117490
  29. Recent hypotheses regarding the phosphatidylinositol effect.
    Life Sci. 1981 Sep 21;29(12):1183-94 PMID: 7029181
  30. The relationship of phosphatidylinositol turnover to receptors and calcium-ion channels in rat parotid acinar cells.
    Biochem J. 1981 Feb 15;194(2):463-8 PMID: 6171259
  31. Ca2+ mobilization in blood platelets as visualized by chlortetracycline fluorescence.
    Am J Physiol. 1981 Oct;241(4):H613-9 PMID: 6274207
  32. Synthesis of prostanoids with bicyclo[2.2.1]heptane, bicyclo[3.1.1]heptane, and bicyclo[2.2.2]octane ring systems. Activities of 15-hydroxy epimers on human platelets.
    J Med Chem. 1982 May;25(5):495-500 PMID: 7086834
  33. Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea.
    Br J Pharmacol. 1982 Jul;76(3):423-38 PMID: 6286023
  34. Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.
    J Cell Biol. 1982 Aug;94(2):325-34 PMID: 6980885
  35. Regulation of phosphatidate synthesis by secretagogues in parotid acinar cells.
    Biochem J. 1982 May 15;204(2):587-92 PMID: 6180740
  36. Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca-independent activation for shape-change and secretion.
    FEBS Lett. 1982 Nov 1;148(1):21-6 PMID: 6816632
  37. Synergistic activation by collagen and 15-hydroxy-9 alpha,11 alpha-peroxidoprosta-5,13-dienoic acid (PGH2) of phosphatidylinositol metabolism and arachidonic acid release in human platelets.
    J Clin Invest. 1982 Dec;70(6):1216-24 PMID: 6816811
  38. Thrombin-induced phosphodiesteratic cleavage of phosphatidylinositol bisphosphate in human platelets.
    J Biol Chem. 1983 Feb 25;258(4):2076-8 PMID: 6296123
  39. Arachidonate release and phosphatidic acid turnover in stimulated human platelets.
    J Biol Chem. 1983 Feb 25;258(4):2461-7 PMID: 6401733
  40. The enzymology of stimulated inositol lipid turnover.
    Cell Calcium. 1982 Oct;3(4-5):295-309 PMID: 6297738
  41. Inositol lipid metabolism in the responses of stimulated platelets.
    Cell Calcium. 1982 Oct;3(4-5):311-22 PMID: 6760975
  42. Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation.
    Cell Calcium. 1982 Oct;3(4-5):323-35 PMID: 6218878
  43. Ligand-stimulated inositol lipid metabolism in the liver: relationship to receptor function.
    Cell Calcium. 1982 Oct;3(4-5):399-411 PMID: 6297741
  44. A role for cyclooxygenase products in the formation of phosphatidic acid in stimulated human platelets. Differential mechanisms of action of thrombin and collagen.
    J Biol Chem. 1983 Apr 25;258(8):4683-6 PMID: 6403533
  45. Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation.
    J Biol Chem. 1983 Jun 10;258(11):6701-4 PMID: 6406488
  46. Platelet-activating factor stimulates phosphatidylinositol turnover in human platelets.
    Biochem J. 1983 May 15;212(2):433-7 PMID: 6411067
  47. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol.
    Biochem J. 1983 Jun 15;212(3):849-58 PMID: 6309155
  48. Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate.
    Nature. 1983 Nov 3-9;306(5938):67-9 PMID: 6605482
  49. Ligand binding to thromboxane receptors on human platelets: correlation with biological activity.
    Br J Pharmacol. 1983 Aug;79(4):953-64 PMID: 6317122
  50. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
Article Info
Journal
The Biochemical journal
Abbr.
Biochem J
ISSN
0264-6021
Published
1984-05-01
Pages
833-42
Language
English
Region
England
NLM ID
2984726R
PMCID
PMC1153551
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]